RGS vs AMZN vs MSFT vs SKIN vs AAPL

For growth investors, Microsoft Corporation (MSFT) is the stronger pick with 14.

9% revenue growth year-over-year, versus -10. 0% for The Beauty Health Company (SKIN). Regis Corporation (RGS) offers the better valuation at 0. 6x trailing P/E, making it the more compelling value choice. Analysts rate Amazon. com, Inc. (AMZN) a "Buy" — based on 94 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, Regis Corporation (RGS) is the cheapest at 0.

6x versus Apple Inc. at 39. 3x. On forward P/E, Microsoft Corporation is actually cheaper at 24. 8x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Amazon. com, Inc. wins at 1. 12x versus Apple Inc. 's 1. 89x — a reasonable growth-adjusted valuation.

Over the past 5 years, Apple Inc.

(AAPL) delivered a total return of +134. 8%, compared to -95. 3% for The Beauty Health Company (SKIN). Over 10 years, the gap is even starker: AAPL returned +1199% versus SKIN's -94. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Regis Corporation (RGS) is the lower-risk stock at 0.

77β versus The Beauty Health Company's 1. 71β — meaning SKIN is approximately 123% more volatile than RGS relative to the S&P 500. On balance sheet safety, Microsoft Corporation (MSFT) carries a lower debt/equity ratio of 33% versus 6% for The Beauty Health Company — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Microsoft Corporation (MSFT) is pulling ahead at 14.

9% versus -10. 0% for The Beauty Health Company (SKIN). On earnings-per-share growth, the picture is similar: The Beauty Health Company grew EPS 55. 6% year-over-year, compared to 13. 9% for Regis Corporation. Over a 3-year CAGR, MSFT leads at 12. 4% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Regis Corporation (RGS) is the more profitable company, earning 58.

8% net margin versus -3. 2% for The Beauty Health Company — meaning it keeps 58. 8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: MSFT leads at 45. 6% versus -6. 9% for SKIN. At the gross margin level — before operating expenses — MSFT leads at 68. 8%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, Amazon. com, Inc. (AMZN) is the more undervalued stock at a PEG of 1. 12x versus Apple Inc. 's 1. 89x. A PEG below 1. 5 suggests fair-to-attractive pricing relative to expected growth. On forward earnings alone, Microsoft Corporation (MSFT) trades at 24. 8x forward P/E versus 33. 7x for Apple Inc. — 8. 9x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for SKIN: 124. 1% to $1. 30.

In this comparison, MSFT (0.

8% yield), AAPL (0. 4% yield) pay a dividend. RGS, AMZN, SKIN do not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, Microsoft Corporation (MSFT) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

85), 0. 8% yield, +776. 0% 10Y return). The Beauty Health Company (SKIN) carries a higher beta of 1. 71 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (MSFT: +776. 0%, SKIN: -94. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (RGS (Consumer Cyclical) and AMZN (Consumer Cyclical) and MSFT (Technology) and SKIN (Consumer Defensive) and AAPL (Technology)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: RGS is a small-cap deep-value stock; AMZN is a mega-cap quality compounder stock; MSFT is a mega-cap quality compounder stock; SKIN is a small-cap quality compounder stock; AAPL is a mega-cap quality compounder stock. MSFT pays a dividend while RGS, AMZN, SKIN, AAPL do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.